Immunome annual revenue
2022
2023
2024
2025
Immunome Revenue Growth & History (IMNM)
Immunome reported $6.9M in revenue for fiscal 2025, a decrease of 23.23% from the previous fiscal year.
View full Immunome company overviewImmunome annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.9M | −$2.1M | −23.23% |
| 2024 | 2024-12-31 | $9.0M | −$5.0M | −35.50% |
| 2023 | 2023-12-31 | $14.0M | $14.0M | — |
| 2022 | 2022-12-31 | $0 | — | — |
Immunome quarterly revenue
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$4.0M | −100.00% |
| Q1 2026 | 2026-03-31 | $0 | −$2.9M | −100.00% |
| Q4 2025 | 2025-12-31 | $0 | −$2.7M | −100.00% |
| Q3 2025 | 2025-09-30 | $0 | −$2.9M | −100.00% |
| Q2 2025 | 2025-06-30 | $4.0M | $1.7M | +69.84% |
| Q1 2025 | 2025-03-31 | $2.9M | $1.9M | +184.35% |
| Q4 2024 | 2024-12-31 | $2.7M | −$1.1M | −28.44% |
| Q3 2024 | 2024-09-30 | $2.9M | −$655,000 | −18.37% |
| Q2 2024 | 2024-06-30 | $2.4M | −$1.9M | −44.55% |
| Q1 2024 | 2024-03-31 | $1.0M | −$1.3M | −56.47% |
| Q4 2023 | 2023-12-31 | $3.8M | — | — |
| Q3 2023 | 2023-09-30 | $3.6M | — | — |
| Q2 2023 | 2023-06-30 | $4.3M | — | — |
| Q1 2023 | 2023-03-31 | $2.4M | — | — |
Immunome revenue growth trends
Immunome's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Immunome source filings ↗